| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |